Non-Opioid Pain Management
•12 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (12)
| Company | Market Cap | Price |
|---|---|---|
|
VRTX
Vertex Pharmaceuticals Incorporated
JOURNAVX is a non-opioid pain management therapy, aligning with the non-opioid pain management investable theme.
|
$126.01B |
$491.69
+5.74%
|
|
VTRS
Viatris Inc.
Pipeline includes non-opioid pain management options (e.g., fast-acting meloxicam) as growth drivers.
|
$18.39B |
$15.78
-0.06%
|
|
AXSM
Axsome Therapeutics, Inc.
Symbravo's non-opioid analgesic profile supports Non-Opioid Pain Management as a broader category.
|
$9.04B |
$181.32
-0.89%
|
|
ATRC
AtriCure, Inc.
Pain-management devices (cryoSPHERE family, cryoXT) provide non-opioid analgesia, a key product category.
|
$1.62B |
$32.59
+2.48%
|
|
LXRX
Lexicon Pharmaceuticals, Inc.
Pilavapadin is a non-opioid pain management therapy in development for neuropathic pain, constituting a non-opioid analgesic product category.
|
$476.05M |
$1.31
+0.38%
|
|
ANIK
Anika Therapeutics, Inc.
Non-opioid pain management solutions through HA injections address OA pain.
|
$147.21M |
$10.22
+1.59%
|
|
ASRT
Assertio Holdings, Inc.
INDOCIN, SPRIX, and CAMBIA represent non-opioid analgesics, supporting the Non-Opioid Pain Management theme.
|
$79.40M |
$12.36
+1.23%
|
|
CPIX
Cumberland Pharmaceuticals Inc.
Caldolor is a non-opioid IV analgesic, aligning CPIX with non-opioid pain management products.
|
$58.04M |
$3.88
+2.51%
|
|
SCLX
Scilex Holding Company
Core business focused on non-opioid pain management drugs and a pipeline of non-opioid therapies.
|
$57.80M |
$8.39
+1.63%
|
|
GRCE
Grace Therapeutics, Inc.
GTx-101.00 is a non-narcotic topical analgesic in development for PHN, supporting the 'Non-Opioid Pain Management' theme.
|
$51.00M |
$3.62
+2.55%
|
|
MIRA
MIRA Pharmaceuticals, Inc.
The company's pain therapies are non-opioid analgesics, placing them under 'Non-Opioid Pain Management'.
|
$22.12M |
$1.17
-1.27%
|
|
APUS
Apimeds Pharmaceuticals US, Inc
Apitox functions as a non-opioid analgesic for pain management, aligning with the Non-Opioid Pain Management investable theme.
|
$15.47M |
$1.29
+17.27%
|
Loading company comparison...
Loading industry trends...
Loading research report...
